A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight

Clinical trial NCT06712836 · COMPLETED

Trial details

NCT number: NCT06712836
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Overweight or Obesity

Start date: 2024-10-09
Primary completion: 2025-07-03
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.